Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duration of Oseltamivir Prophylaxis
NCT03899571Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jan 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of oseltamivir in influenza (2 arms), sponsored by University Medical Centre Ljubljana. Primary endpoint: Occurrence of influenza like illness 10 days after oseltamivir prophylactic therapy. Started Jan 2019; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03899571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899571.